Study record managers: refer to the Data Element Definitions if submitting registration or results information.| clinicaltrials.gov
A Phase 2/3 trial testing buntanetap in Alzheimer's patients is expected to be fully enrolled next month, with data expected in March 2024.| Alzheimer's News Today
A tool called focused ultrasound may help antibody-based treatments better reach the brain and clear away toxic protein clumps in Alzheimer's.| Alzheimer's News Today
An available blood test was found to identify Alzheimer's patients with and without tau and/or amyloid-beta clumps, needed for treatment.| Alzheimer's News Today
Buntanetap lowered amyloid-beta and tau levels in people with early Alzheimer's disease and its developer Annovis Bio is planning more trials.| Alzheimer's News Today
Lindsey Shapiro is a science writer for Alzheimer's News Today with a PhD in neuroscience. She covers the latest news and information on a variety of Alzheimer's topics.| Alzheimer's News Today
Read a summary of the causes Alzheimer's disease, inclouding neurofibrillary tangles, inflammation, vascular and environmental factors, genetics and aging.| Alzheimer's News Today
Taking on caregiving for a loved one with Alzheimer's can seem impossible, says columnist Ray Burow, but only until it's done.| Alzheimer's News Today
Category archive page for Columns.| Alzheimer's News Today
Category archive page for News.| Alzheimer's News Today
Learn about Parkinson's disease, a condition that affects the brain, resulting in issues with movement, balance, and more.| Parkinson's News Today
Learn more about Alzheimer's disease, the most common cause of dementia and an irreversible, progressive neurological disorder.| Alzheimer's News Today
